Clinical Trial Categories
Benign Hematology Trials
Trial ID 21367
NCT05155605clinicaltrials.gov ID
USOR ID: 21367
The PATHFINDER 2 Study: Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population
Trial ID 21473
NCT05171049clinicaltrials.gov ID
USOR ID: 21473
Phase III
ASTER: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE
